Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes
- PMID: 16880248
- DOI: 10.1542/peds.2005-2033
Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes
Abstract
Objective: This study was a comparison of topical ciprofloxacin/dexamethasone otic suspension to oral amoxicillin/clavulanic acid suspension in children with acute otitis media with otorrhea through tympanostomy tubes.
Methods: This was a randomized, observer-masked, parallel-group, multicenter trial of topical ciprofloxacin/dexamethasone otic suspension versus amoxicillin/clavulanic acid suspension in 80 children aged 6 months to 12 years with acute otitis media with otorrhea through tympanostomy tubes of < or = 3 weeks' duration and visible otorrhea. Patients were randomly assigned to receive either 4 drops of topical ciprofloxacin 0.3%/dexamethasone 0.1% (Ciprodex Sterile Otic Suspension) into the affected ear(s) twice daily for 7 days or 600 mg of amoxicillin/42.9 mg of clavulanic acid oral suspension (Augmentin ES-600 Oral Suspension) every 12 hours for 10 days. Clinical signs and symptoms of acute otitis media with otorrhea through tympanostomy tubes were evaluated on days 1 (baseline), 3, 11 (end-of-therapy), and 18 (test-of-cure), and twice-daily assessments of otorrhea were recorded in patient diaries.
Results: The median time to cessation of otorrhea was significantly shorter with ciprofloxacin/dexamethasone otic suspension than with amoxicillin/clavulanic acid suspension (4.0 vs 7.0 days; n = 79). This resulted in significantly more clinical cures at the test-of-cure visit (85% vs 59%, respectively). Frequent adverse events (> 3%) related to ciprofloxacin/dexamethasone otic suspension included ear pain (5.1%) and related to amoxicillin/clavulanic acid suspension included diarrhea (19.5%), dermatitis (7.3%), and gastroenteritis (4.9%).
Conclusions: Topical otic treatment with ciprofloxacin/dexamethasone otic suspension is superior to treatment with oral amoxicillin/clavulanic acid suspension and results in more clinical cures and earlier cessation of otorrhea with fewer adverse effects in children with acute otitis media with otorrhea through tympanostomy tubes.
Comment in
-
Why don't those ear drops work for my patients?Pediatrics. 2006 Sep;118(3):1252-3. doi: 10.1542/peds.2006-0826. Pediatrics. 2006. PMID: 16951020 No abstract available.
Similar articles
-
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. doi: 10.1542/peds.113.1.e40. Pediatrics. 2004. PMID: 14702493 Clinical Trial.
-
Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.Laryngoscope. 2003 Dec;113(12):2116-22. doi: 10.1097/00005537-200312000-00011. Laryngoscope. 2003. PMID: 14660913 Clinical Trial.
-
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes.Otolaryngol Head Neck Surg. 2004 Jun;130(6):736-41. doi: 10.1016/j.otohns.2004.02.037. Otolaryngol Head Neck Surg. 2004. PMID: 15195060 Clinical Trial.
-
Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.Pediatr Infect Dis J. 2009 Feb;28(2):141-4. doi: 10.1097/INF.0b013e31818b0c9c. Pediatr Infect Dis J. 2009. PMID: 19116600 Review.
-
Ciprofloxacin 0.3% + dexamethasone 0.1% for the treatment for otitis media.Expert Opin Pharmacother. 2013 Dec;14(17):2399-405. doi: 10.1517/14656566.2013.844789. Epub 2013 Oct 7. Expert Opin Pharmacother. 2013. PMID: 24093464 Review.
Cited by
-
Otology/Neurotology recommendations - Choosing Wisely campaign.J Otolaryngol Head Neck Surg. 2019 Nov 8;48(1):60. doi: 10.1186/s40463-019-0381-4. J Otolaryngol Head Neck Surg. 2019. PMID: 31703748 Free PMC article.
-
An extended release ciprofloxacin/dexamethasone hydrogel for otitis media.Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110311. doi: 10.1016/j.ijporl.2020.110311. Epub 2020 Aug 18. Int J Pediatr Otorhinolaryngol. 2020. PMID: 32891940 Free PMC article.
-
Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion.Cochrane Database Syst Rev. 2016 Nov 17;11(11):CD011684. doi: 10.1002/14651858.CD011684.pub2. Cochrane Database Syst Rev. 2016. PMID: 27854381 Free PMC article.
-
Ciprofloxacin safety in paediatrics: a systematic review.Arch Dis Child. 2011 Sep;96(9):874-80. doi: 10.1136/adc.2010.208843. Epub 2011 Jul 23. Arch Dis Child. 2011. PMID: 21785119 Free PMC article.
-
Treatment Options to Manage Wound Biofilm.Adv Wound Care (New Rochelle). 2012 Jun;1(3):120-126. doi: 10.1089/wound.2011.0300. Adv Wound Care (New Rochelle). 2012. PMID: 24527291 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical